2,2',4,4'-tetrabromodiphenyl ether and Cirrhosis

2,2',4,4'-tetrabromodiphenyl ether has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Z; Chung, ACK; Kang, Q; Lee, HK; Li, D; Yang, C; Zhu, L	1

Other Studies

1 other study(ies) available for 2,2',4,4'-tetrabromodiphenyl ether and Cirrhosis

Article	Year
Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice. Journal of hazardous materials, 2019, 10-15, Volume: 378 Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diet; Diet, High-Fat; Fatty Liver; Fibrosis; Halogenated Diphenyl Ethers; Hepatocytes; Inflammation; Lipid Metabolism; Lipid Peroxidation; Lipidomics; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidative Stress	2019

Article

Year

Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice.

Journal of hazardous materials, 2019, 10-15, Volume: 378

Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diet; Diet, High-Fat; Fatty Liver; Fibrosis; Halogenated Diphenyl Ethers; Hepatocytes; Inflammation; Lipid Metabolism; Lipid Peroxidation; Lipidomics; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Oxidative Stress

2019